Use of alginates in the treatment of persistent throat symptoms

  • Research type

    Research Study

  • Full title

    Factors influencing the use of alginates in the treatment of persistent throat symptoms: patient and clinician insight generation

  • IRAS ID

    290065

  • Contact name

    David Hamilton

  • Contact email

    david.hamilton3@nhs.net

  • Sponsor organisation

    The Newcastle upon Tyne Hospitals NHS Foundation Trust

  • Duration of Study in the UK

    0 years, 11 months, 31 days

  • Research summary

    Persistent throat symptoms (PTS) are a very common presentation to the ear, nose and throat department. Ear, nose and throat surgeons see a huge number of patients with symptoms such as a feeling of lump in throat, throat clearing, voice hoarseness, cough , gritty throat etc. Patients are often very concerned and have sought advice from the internet or the GP, sometimes on multiple occasions, and have often tried over the counter remedies. It is thought that a lot of these symptoms are caused by the effects of stomach acid on the throat. In this way PTS makes up a large proportion of the ear, nose and throat department workload. GP's and specialists commonly prescribe proton pump inhibitors (PPIs) in order to try and combat these symptoms by reducing the amount of acid in the stomach. The research team in Newcastle recently demonstrated with a large randomised controlled trial (recently published in the BMJ) that PPI drugs are not effective against PTS.

    In this study we seek to explore the patient's perspective of living with PTS and of treating it. Using in depth qualitative interviews we will ask patients about their experience of living with the symptoms and of the measures that they have taken to try and combat them. Specifically we would like to know the sorts of measures that they have taken, their relative success and their experience of seeking out professional advice. Many patients have tried aliginates such as Gaviscon with variable amounts of success. We will explore whether patients have trailed alginates, how long they have persisted for and what other interventions they tried at the same time. We will explore the language that they use surrounding PTS and its treatment. The results of this work will help us to understand the patient experience of the disease and treatment but also help us to develop a trial into the use of alginates in the treatment of persistent throat symptoms.

  • REC name

    HSC REC A

  • REC reference

    21/NI/0186

  • Date of REC Opinion

    20 Jan 2022

  • REC opinion

    Further Information Favourable Opinion